The trademark BiME was filed by Elpiscience Biopharma, Ltd., a corporation established under the laws of the People's Republic of China (the "Applicant"). The application was published for oppositions on July 14, 2021, and received undefined oppositions.
There are undefined Oppositions claimed against trademark.
The first opposition filed on October 14, 2021 by Owen Mumford Limited on (a) Likelihood of confusion, (b) Unfair advantage and detriment to distinctiveness or repute. the opponent was represented by Stobbs Ireland Limited and its proceedings were handled in English The second opposition filed on October 11, 2021 by BIMEDA ANIMAL HEALTH LIMITED on (a) Likelihood of confusion, (b) Unfair advantage and detriment to distinctiveness or repute. the opponent was represented by TOMKINS & CO. and its proceedings were handled in English
The application was filed in English, and English was also language of all opposition proceedings (Italian was selected as the second language).
The Opposition with reference B 003156412 was partially refused EUTMA/IR according to Article 8(1)(b) EUTMR with decision issued on December 19, 2022 by the EUIPO.